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Copyright © 200? JCBN 200? This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unre- stricted use, distribution, and reproduction in any medium, pro- vided the original work is properly cited. Stanniocalcin 1 and stanniocalcin 2 are two glycoprotein hormones,
which act as calcium phosphate-regulating factor on intestine and
kidney. We have previously reported that stanniocalcin 2 expres-
sion is positively and negatively controlled by 1,25(OH)2D3 and
parathyroid hormone in renal proximal tubular cells. However, it
has been unclear whether they regulate the stanniocalcin 1 gene
expression. In this study, we identified the opossum stanniocalcin
1 cDNA sequence. The opossum stanniocalcin 1 amino acid
sequence had 83% homology with human stanniocalcin 1, and
has a conserved putative N-linked glycosylation site. Real-time
PCR analysis using opossum kidney proximal tubular (OK-P) cells
revealed that the mRNA levels of stanniocalcin 1 gene is up-
regulated by both 1,25(OH)2D3 and parathyroid hormone in dose-
dependent and time-dependent manners. We also demonstrated
that the stanniocalcin 1 expression was increased in parathyroid
hormone injected rat kidney. Furthermore, the mRNA expression
of stanniocalcin 1 and stanniocalcin 2 were oppositely regulated
by phorbol 12,13-myristic acetate, a specific PKC activator. Inter-
estingly, the up-regulation of stanniocalcin 1 gene by 1,25(OH)2D3
and phorbol 12,13-myristic acetate were not prevented in the
presence of actinomycin D, an RNA synthesis inhibitor. These
results suggest that the stanniocalcin 1 gene expression is up-
regulated by 1,25(OH)2D3 and parathyroid hormone through mRNA
stabilization in renal proximal tubular cells.
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Introduction Stanniocalcin (STC) is a glycoprotein hormone first identified
from the corpuscles of Stannius in bony fish, endocrine
glands that are embryologically derived from the kidney tubules.(1,2)
An increase in plasma ionized calcium levels is the principal
stimulus for secretion and one of the primary roles of STC in
fishes is preventing the development of hypercalcemia.(3) Indeed,
fish STC acts on gill, gut and kidney as a calcium and phosphate-
regulating hormone.(3–5) Fish and mammals express two
stanniocalcin genes, STC1 and STC2.(6) STC1 and STC2 contain N-
glycosylation sites, a signal peptide sequence of ~24 amino acids.
Localization of STC1 expression in kidney was examined by in
situ hybridization and immunohistochemistry. In rat kidney, the
STC1 gene was expressed in the collecting ducts and distal
nephron segments.(7) Other reports, however, showed STC1
protein expression in the proximal tubules (proximal straight
tubules).(8) Indeed, it has been known that STC1 stimulates phos-
phate reabsorption in the small intestine and proximal tubules of
the kidney.(9,10) We have previously identified human STC2 gene
and observed that the STC2 gene is widely expressed in mice. We
also examined the STC2 mRNA expression in hypophosphatemic
(Hyp) mice, which is a model of human X-linked hypophos-
phatemic vitamin D-resistant rickets (XLH) and found it was
down-regulated in many organs, and human STC2 decreases
phosphate uptake activity and human type IIa sodium-dependent
phosphate co-transporter (human NaPi-2a) gene promoter activity
in opossum renal proximal tubular cell line (OK cells).(11) Our
recent work reported the identification of opossum STC2 gene
and observed that its expression and secretion in OK cells were
positively and negatively controlled by 1,25-dihydroxyvitamin
D3 [1,25(OH)2D3] and parathyroid hormone (PTH).(12) On the other
hand, renal STC1 mRNA expression is increased by calcium and
1,25(OH)2D3 in rat and its renal expression are also up-regulated
in alpha klotho mutant mice indicating hyperphosphatemia,
hypercalcemia and hypervitaminosis D.(13) However, there is no
evidence the regulation of STC1 expression by 1,25(OH)2D3 and
PTH in renal proximal tubular cells in vitro or whether PTH can
affect on its renal expression in vivo.
In the present study, we identified the opossum STC1 cDNA
sequence and investigated the regulation of STC1 gene expression
by 1,25(OH)2D3 and PTH in renal proximal tubular cells.
Materials and Methods
Cell culture and treatments. Opossum kidney proximal
tubular (OK-P) cells were a gift from Dr. Judith A. Cole (Depart-
ment of Biology, University of Memphis, Memphis, TN). OK-P
cells were cultured as described previously.(12) 1,25(OH)2D3 was
obtained from Solvay Pharmaceuticals (Marietta, GA). 22-
oxacalcitriol (OCT) and 2β-(3-hydroxypropoxy) calcitriol (ED-
71) were kindly provided by Chugai Pharmaceutical Co., Ltd.
(Tokyo, Japan). Human parathyroid hormone (1–34 fragment)
(PTH), 8-bromo-cyclic AMP (8b-cAMP), phorbol 12,13-myristic
acetate (PMA) and actinomycin D (ActD) were purchased from
Sigma-Aldrich. After reaching 100% confluence, OK-P cells were
treated with each reagent at different concentrations and times.
cDNA isolation and DNA sequence analysis. Opossum 
STC1 gene information was obtained from a BLAST search on
the UCSC Genome Bioinformatics website (http://www.genome.




basis of this information, oligonucleotide primers specific to the
STC1 cDNA sequence were synthesized. The sequences of the
upstream and downstream primers were 5'-TCAGAGAATGCT
CCACAACTCC-3', and 5'-CTGCCTCGGTTACTCGCTCT-3'
respectively. Opossum STC1 cDNA containing an open reading
frame was amplified by RT-PCR using total RNA isolated from
OK-P cells. The amplification products were purified and
subcloned into a pGEM-T Easy vector (Promega), and manually
sequenced using the dye terminator cycle sequencing method
(Applied Biosystems, Foster City, CA). The cDNA sequences of
the opossum STC1 gene have been deposited in GenBank (http://
www.ncbi.nlm.nih.gov) under the accession number AB622590.
Reverse transcription (RT)-PCR and quantitative real-time
RT-PCR. The cells were homogenized in RNA iso plus reagent
(Takara Bio Inc., Shiga, Japan). After phenol/chloroform extrac-
tion and 2-propanol precipitation, total RNA was dissolved in
RNase-free water. First-strand cDNA was synthesized from
2.5 μg of total RNA, primed with oligo (dT) using the MMLV-
reverse transcriptase (Invitrogen, San Diego, CA). Two μl of the
cDNA was then used for subsequent PCR, with 20–30 cycles of
amplification, and then PCR products were separated by electro-
phoresis using 2% agarose gels. For PCR amplification, the primer
sequences were: opossum STC1, 5'-CAGAGAATGCTCCAC
AACTCCGCC-3' and 5'-CTGCAGAGCAGTGTTGAGGCAT
CGG-3'; opossum STC2, 5'-ATGCCCTGAATGGTAAAGCCC
ATG-3' and 5'-CACGTAGGGTTCATGCAGTAGCAGATC-3';
opossum β-actin, 5'-CTGACCCTGAAGTACCCCATTGAACA-
3' and 5'-CTGGGGTGTTGAAGGTCTCAAACATG-3'; rat STC1,
5'-CCAAGGTCTTCCTTGCCATT-3' and 5'-TGCTGCAAACA
T TGAGCTTG-3'; rat β-actin, 5'-GTCCCAGTATGCCTCTGG
TCGTAC-3' and 5'-CCACGCTCGGTCAGGATCTTCATG-3'.
RT-PCR was performed with a PCR system (ASTEC, Fukuoka,
Japan) using Go Taq Master Mix (Promega, Madison, WI). Real-
time PCR analysis was performed using the LightCyclerTM (Roche
Diagnostics, Tokyo, Japan). The prepared first-strand cDNA was
PCR amplified using Light Cycler fast start DNA master SYBR
Premix Ex Taq (Takara Bio Inc., Shiga, Japan) in a 20 μl reaction
volume, with 4 pmol of each primer. β-actin was used as the
internal control. The amplification program was 95°C for 10 s
followed by 50 cycles of 95°C for 10 s, 60°C for 15 s, and 72°C
for 15 s. Amplified products were then analyzed using a melting
curve, which confirmed the presence of a single PCR product in all
reaction (apart from negative control). The products were quantified
by fit-point analysis, and results for STC1 and STC2 were normal-
ized to those of β-actin.
Experimental animals. Eight-week-old Sprague-Dawley (SD)
male rats were purchased from Japan SLC, Inc. (Shizuoka,
Japan). Rats were maintained with 12 h light: 12 h darkness cycles
with free access to regular rat chow and water under pathogen-free
conditions. The breeding and handling of all animals in these
experiments was approved by the Animal Experimentation
Committee of the University of Tokushima. Rats were fed a low-
phosphate diet (0.02% Pi and 0.6% Ca) for 3 days.(14) Then,
human-PTH (1–34) (10 μg/100 g body weight) was injected into
the jugular vein. After treatment for 0.5 h, the rats were sacrificed.
Western blot analysis. The whole kidney was homogenized
in lysis buffer containing 1% Triton X-100, 1% Na deoxycholate,
0.1% SDS, 10 mM Tris-HCl, pH 8.0, 140 mM NaCl. Protein
samples were electrophoresed on 12% SDS/PAGE and transferred
to PVDF membrane (Immobilon-P, Millipore). The membrane
were treated with diluted anti-STC1 antibody (1:1000) (Santa
Cruz) and anti-NaPi-2a antibody (1:5000). Mouse anti-actin
monoclonal antibody (Sigma) was used as an internal control.
Horseradish peroxidase (HRP)-labeled anti-IgG (Bio-Rad) was
utilized as the secondary antibody, and signal were detected using
the ECL plus system (GE Healthcare, Buckinghamshire, UK).
Statistical analysis. Data are expressed as means ± SD.
Statistical significance between groups was determined using
ANOVA followed by post hoc testing using Fisher’s protected
least significant difference (PLSD). p<0.05 was considered to be
significant.
Results
Identification of opossum STC1 amino acid sequences.
We first identified opossum STC1 cDNA using information
obtained from the UCSC genome database website. The opossum
STC1, human STC1 sequences and opossum STC2 were then
aligned. We assessed STC1 in opossum and human, and STC1 and
STC2 in opossum. The results presented in Fig. 1A showed that
opossum STC1 amino acid sequence had 83.7% homology with
human STC1, and conserved 11 cysteine residues and a putative
N-linked glycosylation site as well as human STC1. We next
compared the amino acid sequence of opossum STC1 with that of
opossum STC2. Although it was seen at 10 conserved cysteine
residues and a putative N-linked glycosylation site, it had only
35.3% homology.
Regulation of STC1 mRNA expressions by 1,25(OH)2D3 in
opossum kidney cells. In our previous study, we identified
opossum STC2 and demonstrated the STC2 gene expression in
OK-P cells was up-regulated by 1,25(OH)2D3 in transcriptional
control, but PTH and PMA as the PKC activator down-regulated
its expression.(12) In this experiment, we investigated about the
regulation of STC1 gene by 1,25(OH)2D3, PTH and PMA, and
compared with the STC2 gene expression. Using Reverse
Transcript-PCR and Real time PCR, we now investigated whether
the STC1 mRNA expression in OK-P cells is controlled by
1,25(OH)2D3 and PTH. As shown in Fig. 2A, 1,25(OH)2D3
increased both the mRNA levels of STC1 and STC2 in OK-P cells.
Real-time quantitative PCR analyses revealed that 1,25(OH)2D3
increases the STC1 mRNA levels in OK-P cells in a dose- and
time-dependent manner (Fig. 2 B and C). However, the efficacy of
1,25(OH)2D3 for the STC1 gene was 10-folds less than STC2 gene
(Fig. 2B). The up-regulation of STC1 gene expression by
1,25(OH)2D3 was evident at 1 h and reached its peak at 6 h, with a
7-folds increase at the time (Fig. 2C). In addition, we found the
STC1 mRNA expression is also up-regulated by OCT and ED-71,
which is 1,25(OH)2D3 analogs (Fig. 2D).
Up-regulation of STC1 mRNA expression by PTH in vitro
and in vivo. We then determined whether PTH affects on the
STC1 mRNA expression in OK-P cells. 6 h treatment with PTH in
OK-P cells significantly increased the levels of STC1 mRNA, but
decreased that of STC2 mRNA (Fig. 3A). The opposite effects of
PTH on the mRNA expression of STC1 and STC2 were observed
in time-dependent manners (Fig. 3B). In addition, we confirmed
the effects of PTH on renal STC1 expression in vivo. As shown
in Fig. 3C, the renal mRNA levels of STC1 was significantly
increased at both periods of 0.5 h and 3 h after PTH injection. It
has been well-known that the renal NaPi-2a expression is down-
regulated by PTH.(15–17) Therefore, we also investigated the renal
NaPi-2a expression as a good PTH target gene. Western blot
analysis showed that PTH increased the protein levels of STC1,
but decreased that of NaPi-2a (Fig. 3D).
PMA stimulates STC1 mRNA expression in OK-P cells.
To gain further understanding of the mechanisms involved in the
regulation of the STC1 gene by PTH, we observed that the effects
of 8-brommo-cyclic AMP as a PKA activator and PMA as a PKC
activator on the STC1 mRNA expression in OK-P cells. As
showed in Fig. 4A, the STC1 mRNA levels were significantly
increased by PMA, but not 8-brommo-cyclic AMP. Dose- and time-
dependent experiments showed that PMA oppositely controlled
the mRNA levels of STC1 and STC2 gene in OK-P cells as well as
PTH (Fig. 4 B and C). Furthermore, PMA and 1,25(OH)2D3
additively increased the STC1 mRNA levels, however, PMA com-
pletely suppressed 1,25(OH)2D3-induced STC2 mRNA expression
(Fig. 4D). J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 229
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Stabilization of STC1 mRNA by 1,25(OH)2D3 and PMA in
OK-P cells. Our previous study using ActD indicated that the
opossum STC2 gene expression was up-regulated by 1,25(OH)2D3
at transcriptional levels.(12) Surprisingly, pretreatment with ActD
did not suppressed 1,25(OH)2D3 or PMA-induced STC1 mRNA
expression in the OK-P cells (Fig. 5 A and B). To determine if the
elevation in STC1 mRNA was associated with enhanced mRNA
stability, we performed a standard mRNA decay assay. ActD was
added to OK-P cells to prevent any new gene transcription, and
STC1 mRNA levels were monitored over the following 12-h
period in cells treated with ActD only and in cells treated with
ActD plus either 1,25(OH)2D3 or PMA. As shown in Fig. 5 C and
D, the half-life of STC1 mRNA in ActD-treated cells was about
2.5 h; 1,25(OH)2D3 and PMA treatments increased the half-life
~2.5-fold (to 12 h) and ~3-fold (6 h), respectively. These results
indicate that both 1,25(OH)2D3 and PMA induce STC1 mRNA
levels primarily by inhibiting its decay.
Discussion
The present study characterized a cDNA that encodes STC1 in
opossum and investigated the effects of 1,25(OH)2D3 and PTH
on STC1 mRNA levels in renal proximal tubular cells. Fig. 1A
indicated that the opossum STC1 amino acid sequence have
showed 83.7% homology with human STC1. More importantly,
the deduced amino acid sequence of opossum STC1 has features
perfectly conserved with the 11 cysteine residues and the unique
N-linked glycosylation site of human STC1.(18–20) Although
opossum STC1 showed a lower sequence identity of 35.3%
sequence homology with opossum STC2, we found that the
position of key cysteine residues and the N-linked glycosylation
site are strictly conserved between opossum STC1 and opossum
STC2 (Fig. 1B). These results consisted with our previous report
for the identification of human STC2 cDNA sequence and the
homology with human STC1.(11) It has been assumed that STC1
and STC2 have overlapping functions because of their similarities
in primary amino acid sequence.(20,21) However, human STC1
inhibits calcium transport activity on gill in fish, but not human
STC2.(3,22) Furthermore, high-affinity STC1-binding are observed
on both the plasma membrane and mitochondria in nephron
epitherial cells and liver hepatocytes, but, STC2 is unable or weakly
capable of displacing STC1 in receptor binding assays.(23–28) These
evidences strongly suggest that the biological roles of STC1 in
mammals may differ from those of STC2.
We have previously reported STC2 expression is positively and
negatively regulated by 1,25(OH)2D3 and PTH in the renal
proximal tubular cells.(12) RT-PCR and real-time PCR analysis
indicated that both STC1 and STC2 mRNA expressions were
increased by 1,25(OH)2D3. These results could support previous
in vivo experiments that 1,25(OH)2D3 could increase the STC1
Fig. 1. Identification of opossum STC1 amino acid sequences. Opossum STC1 cDNA was cloned by RT-PCR analysis using information obtained from
the UCSC genome database website. The amino acid sequences of opossum STC1 were then aligned with (A) human STC1 and (B) opossum STC2.
The underlined sequence indicated the predicted signal peptide region. The N-glycosylation site is shown as a closed triangle. The conserved cysteine
residues are indicated by black dots.doi: 10.3164/jcbn.11-99
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Fig. 2. Effects of 1,25(OH)2D3 on the STC1 mRNA expressions in OK-P
cells. When OK-P cells reached confluence, the cells were treated with
the control (final concentration of ethanol, 0.1%) or (A) 100 nM 1,25D3
for 6 h, or multiple concentrations of (B) 1,25D3 for 6 h, or (C) 100 nM
1,25D3 for time course study. (D) The cells were also incubated with the
control, 100 nM 1,25D3, OCT or ED-71 for 6 h. RNA was extracted from
cells at the indicated time points, and RT-PCR or real-time RT-PCR was
performed to evaluate STC1 and STC2 expression. Results were normal-
ized to the mRNA expression level of β-actin. The data are represented
as the means ± SD (n =3 ) .  * p<0.05, **p<0.001 compared with control.
Fig. 3. Effects of PTH on the STC1 expression in OK-P cells and rat kid-
ney. (A, B) OK-P cells were incubated with the control (final concentra-
tion of ethanol, 0.1%) and 100 nM PTH for 6 h or different periods of
time. The mRNA levels of STC1 and STC2 in OK-P cells were determined
by RT-PCR and real-time PCR analysis. (C, D) SD male rats were fed a
low-phosphate diet for 3 days, low-phosphate diet contained 0.02% Pi
and 0.6% Ca, and then 10 μg human PTH (1–34)/100 g body weight was
injected into the jugular vein. After treatment for 0.5 h and 3 h, the
mRNA expression levels of STC1 in kidney were quantified by real-time
PCR. Results were normalized to the mRNA expression level of β-actin.
Values are means ± SD (n =3 – 5 ) .  * p<0.05, **p<0.001 compared with
control. (D) The renal protein levels of STC1 and NaPi-2a were measured
by western blot analysis. β-actin was used as an internal control. J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 231
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expression in kidney.(13,29,30) Interestingly, we also found that PTH
stimulated the STC1 mRNA expression in OK-P cells and rat
kidney. In contrast, the STC2 gene expression in OK-P cells was
down-regulated by PTH as well as our previous experiment.(12)
Furthermore, we confirmed the decrease of NaPi-2a protein levels
at 0.5 h after PTH treatment (Fig. 3D). Although hyperphos-
Fig. 4. Effects of PMA on the STC1mRNA expression in OK-P cells. (A) OK-P cells were treated with the control or 100 nM 8-bro-cAMP, a specific
PKA activator, or PMA, a specific PKC activator for 3 h. OK-P cells were also treated with (B) the different doses of PMA for 3 h, or (C) 100 nM PMA
for time course study, or (D) 100 nM PMA for 3 h or 100 nM 1,25(OH)2D3 for 6 h. After treatment with 1,25(OH)2D3 and/or PMA, the cells were har-
vested and total RNA was extracted. The mRNA levels of STC1 and STC2 were determined by real-time PCR analysis. Results are expressed as the
means ± SD (n =3 ) .  * p<0.05, **p<0.01 compared with vehicle.doi: 10.3164/jcbn.11-99
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phatemia or hypercalcemia or calcitriol increases the STC1 gene
expression,(13,29,30) we characterized that 1,25(OH)2D3 and PTH
directly up-regulates the STC1 gene in real proximal tubular cells.
Because 1,25(OH)2D3 and PTH have been well-known as major
hormones regulating calcium and phosphate homeostasis in
kidney and intestine,(31) therefore, our finding in this study about
the up-regulation of STC1 gene by 1,25(OH)2D3 and PTH may be
able to understand the physiological significance of STC1 as a
calcium/phosphate-regulating hormone.
PTH binds to the PTH/PTH-related protein receptor on kidney
cells and generates multiple second messengers including cAMP
(which activates PKA), diacylglycerol (which activates PKC),
inositol trisphosphate, and increased levels of intracellular
calcium.(32,33) To determine the stimulatory mechanism of PTH
on STC1 expression, we examined the signaling pathway of PKA
and PKC using 8-bromo-cAMP and PMA, respectively. As shown
in Fig. 4 B and C, PMA increased the STC1 mRNA levels, but
decreased the STC2 mRNA levels in dose- and time-dependent
manners. These data suggest that PTH up-regulates the STC1
expression mediated through the PKC activation in renal proximal
tubular cells. Recently study has been reported that the STC1
expression in kidney is induced by hypertonicity such as NaCl or
mannitol, and the activation of PKC, phospholipase C (PLC) and
inositol 1,4,5-trisphosphate (IP3) is involved in the hypertonicity-
dependent STC1 gene regulation.(34) More interestingly, they
showed that the hypertonicity increased the STC1 mRNA levels
in the cortex, but not in the inner medulla.(34) In fact, we also
observed that after 3 h treatment with PTH in rat significantly
increased the mRNA levels of STC1 in the cortex kidney but not
in the medullar kidney (data not shown).
We finally examined whether or not the stability of the STC1
mRNA could be altered by treatment with 1,25(OH)2D3 and PMA.
In Fig. 5 A and B, surprisingly there was no observation the
suppression of the 1,25(OH)2D3 and PMA induced STC1 mRNA
expression by ActD. Moreover, both of 1,25(OH)2D3 and PMA
increased the stability of STC1 mRNA in the presence of ActD
(Fig. 5 C and D). It has been reported that 1,25(OH)2D3 stabilizes
the osteocalcin mRNA in ROS 17/2.8 cells and c-fms mRNA in
HL-60 cells,(35,36) 5-lipoxygenase mRNA in the human monocytic
cell line Mono Mac 6.(37) In this study, we can not explain how
1,25(OH)2D3 increases the STC1 mRNA in OK-P cells, however,
there is an evidence that the stimulatory effect of Ca2+ on STC gene
expression is due to mRNA stabilization in primary cultured trout
corpuscles of Stannius cells. We now believe that the analysis of
not only the promoter region but also the 3'-untranslated region of
the STC1 gene is necessary to understand the molecular mecha-
nism of STC1 gene regulation.
Importantly, the genome-wide association studies in the chronic
kidney disease (CKD) patients has been identified STC1 and
NaPi-2a (SLC34A1) as one of susceptibility loci in association
with estimated glomerular filtration rate.(38,39) Recent study has
also reported that STC1 has anti-inflammatory and renal protec-
tive actions in a model of anti-glomerular basement membrane
glomerulonephritis.(40) Thus the suitable control of STC1 gene
expression in kidney might be able to contribute provide both
prevention and treatment for CKD.
In summary, we have identified a novel STC1 amino acid
sequence in opossum and demonstrated that STC1 gene is directly
up-regulation by 1,25(OH)2D3 and PTH in renal proximal tubular
OK-P cells, and PTH can increase its renal expression in vivo.
Fig. 5. Stabilization of the STC1 mRNA by 1,25(OH)2D3 and PMA in OK-P cells. OK-P cells were pretreated with 100 nM ActD, then, the cells were
incubated (A) 100 nM 1,25(OH)2D3 for 6 h or (B) 100 nM PMA for 3 h. OK-P cells were treated with (C) 100 nM 1,25(OH)2D3 for 6 h or (D) 100 nM
PMA for 3 h, followed by incubation with 1000 nM ActD for different periods of time. The mRNA expression levels of STC1 were determined by real-
time PCR analysis. Results are expressed as the means ± SD (n =3 ) .  * * p<0.01 compared with vehicle. J. Clin. Biochem. Nutr. | May 2012 | vol. 50 | no. 3 | 233
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Furthermore, we have shown that 1,25(OH)2D3 and PMA regu-
lates the STC1 gene in post-transcriptional levels.
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